Australia markets closed

ZIVO Bioscience, Inc. (9R8.SG)

Stuttgart - Stuttgart Delayed price. Currency in EUR
Add to watchlist
3.21000.0000 (0.00%)
At close: 08:12PM CEST
Show:
Income statement
Balance sheet
Annual

Cash flow

Currency in USD. All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-9,777
-7,777
-8,745
-8,756
-9,106
Stock-based compensation
3,498
867.359
2,692
2,970
1,249
Change in working capital
-466.259
1,281
-355.393
-394.127
2,669
Accounts receivable
-3.735
-3.735
0
-
-
Accounts payable
-121.835
675.09
-163.663
-905.295
187.199
Other working capital
-7,557
-5,800
-7,103
-6,803
-2,588
Other non-cash items
-843.649
-170.736
-694.388
-500.832
297.868
Net cash provided by operating activities
-7,557
-5,800
-7,103
-6,803
-2,588
Cash flows from investing activities
Net cash used for investing activities
0
0
0
0
0
Cash flows from financing activities
Debt repayment
-488.911
-1,756
-628.6
-190.5
0
Common stock issued
1,092
640
0
17,209
400.866
Other financing activities
-
-
-
-1,698
-
Net cash used provided by (used for) financing activities
139.69
4,275
0
15,567
2,380
Net change in cash
-7,417
-1,525
-7,103
8,764
-208.249
Cash at beginning of period
10,803
1,799
8,902
137.862
346.111
Cash at end of period
3,386
274.38
1,799
8,902
137.862
Free cash flow
Operating cash flow
-7,557
-5,800
-7,103
-6,803
-2,588
Free cash flow
-7,557
-5,800
-7,103
-6,803
-2,588